Cargando…
Intracochlear PLGA based implants for dexamethasone release: Challenges and solutions
The effective treatment of diseases of the inner ear is currently an unmet medical need. Local controlled drug delivery to the cochlea is challenging due to the hidden location, small volume and high sensitivity of this organ. A local intracochlear delivery of drugs would avoid the problems of intra...
Autores principales: | Lehner, E., Gündel, D., Liebau, A., Plontke, S., Mäder, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733303/ https://www.ncbi.nlm.nih.gov/pubmed/31517280 http://dx.doi.org/10.1016/j.ijpx.2019.100015 |
Ejemplares similares
-
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
por: Lehner, Eric, et al.
Publicado: (2021) -
Intracochlear drug delivery in combination with cochlear implants: Current aspects
por: Plontke, S. K., et al.
Publicado: (2016) -
Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear
por: Plontke, Stefan K., et al.
Publicado: (2022) -
The Effect of Intracochlear and Intratympanic Dexamethasone on Cochlear Implant Impedance
por: Ardıç, Fazıl Necdet, et al.
Publicado: (2023) -
An Improved Technique of Subtotal Cochleoectomy for Removal of Intracochlear Schwannoma and Single-stage Cochlear Implantation
por: Plontke, Stefan K.
Publicado: (2020)